Creating a paradigm shift in renal care
Quanta Dialysis Technologies, today announces that the Company will be exhibiting at the 55th Annual European Renal Association - European Dialysis and Transplant Association (ERA-EDTA) Congress which runs from Thursday 24th to Sunday 27th May, at the Bella Center in Copenhagen, Denmark at booth number 4.151. Quanta will be showcasing its new look, state-of-the-art personal haemodialysis system, SC+, designed to offer patients flexibility enabling them to fit treatment around everyday life.
Quanta Dialysis Technologies, today announces that the Company has successfully completed a clinical pilot to treat patients in France. Building off its successful UK pilot, this is the first time Quanta's personal haemodialysis system, SC+ has been used outside the UK. The treatments took place over a two-week period with five patients in Hôpital Necker, Paris. The treatments were led by French nurses who were trained by Quanta. These initial treatments in France were in addition to the ongoing pilot study in the UK, which has so far resulted in more than 1,400 successful patient treatments.
Quanta Dialysis Technologies, today announces that the Company will be presenting at the 38th Annual Dialysis Conference (ADC), which runs from 3 to 6 March 2018 at the Marriott Orlando World Center in Florida, USA. Peter Hoyer, Chief Commercial Officer, will provide an update on Quanta's unique small, simple and powerful haemodialysis system, SC+, in the 'Home HD Machines' session chaired by Robert Lockridge, MD, on Sunday 4 March at 2:15pm. The session will include an update on the results of the SC+ Pilot Study, which includes extensive, successful, patient treatments at four NHS Trusts across the UK.